Liberty Mutual Group Asset Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Liberty Mutual Group Asset Management's BIIB Position: Q4 2018 in Review
Liberty Mutual Group Asset Management sold out of Biogen (BIIB) in Q4 2018, closing a stake of 8,434 shares — an estimated $2.98M sold.
Liberty Mutual Group Asset Management first reported a position in BIIB in Q2 2013 and held it in 22 quarters. The position peaked at $7.56M in Q3 2016. 1,141 funds tracked by Wall St. Rank hold BIIB as of Q4 2018.
- Liberty Mutual Group Asset Management reported no remaining Biogen position as of Q4 2018 after selling out during the quarter.
- Liberty Mutual Group Asset Management sold 8,434 Biogen shares in Q4 2018, an estimated $2.98M.
- Liberty Mutual Group Asset Management first reported a position in Biogen in Q2 2013 and held it in 22 quarters.
- Liberty Mutual Group Asset Management's Biogen position peaked at $7.56M in Q3 2016.
- 1,141 funds tracked by Wall St. Rank held Biogen as of Q4 2018.
Based on Liberty Mutual Group Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.